Skip to main content
DNA Labs India

MID1 Gene Opitz G syndrome NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

MID1 Gene Opitz G syndrome NGS Genetic Test

Short Name: MID1 Gene NGS Test

Also known as: MID1 Gene Mutation Test, Opitz G Syndrome NGS Panel, MID1 Sequencing Test, Opitz Syndrome Genetic Test

MID1 Gene Opitz G syndrome NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are typically available within 3 to 4 weeks (21-28 days) after the sample reaches the laboratory. The turnaround time may be extended if additional validation or family studies are required.. Free home collection in 300+ cities across India.

Next Generation Sequencing (NGS)All Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of the MID1 Gene Opitz G Syndrome NGS Genetic Test is to confirm or rule out Opitz G Syndrome in individuals presenting with suggestive clinical features. It also serves to identify carriers, guide reproductive decisions, and facilitate early intervention. The test uses NGS technology, which allows simultaneous sequencing of the entire MID1 gene coding region and intron-exon boundaries, detecting single nucleotide variants, small insertions/deletions, and splice-site mutations. This is essential for accurate diagnosis, as the clinical spectrum of Opitz G Syndrome overlaps with other midline defects. Molecular confirmation enables precise genetic counseling, risk assessment for family members, and recurrence risk estimation.

Test Code
4438
CPT Code
81406
ICD Code
Q87.8
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are typically available within 3 to 4 weeks (21-28 days) after the sample reaches the laboratory. The turnaround time may be extended if additional validation or family studies are required.
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

Complete a genetic counseling session as pre-test counseling is mandatory. Provide a detailed clinical history and any prior laboratory or imaging findings. No fasting required.

Method: Peripheral venipuncture / FTA spot / DNA submission

Step 2

Laboratory Analysis

Blood collection is performed under sterile conditions. For FTA card, a single drop of blood is placed on the designated card and allowed to dry. For extracted DNA submission, ensure sample is labelled and transported in appropriate buffer.

Step 3

Report Delivery

The sample is transported to the laboratory at ambient temperature. Patient can resume normal activities immediately after sample collection.

Timeline: Reports are typically available within 3 to 4 weeks (21-28 days) after the sample reaches the laboratory. The turnaround time may be extended if additional validation or family studies are required.

Patient Instructions

1
Before the Test:A detailed pre-test genetic counseling session is mandatory. In this session, a pedigree will be drawn to assess the family history and inheritance pattern. Please bring previous medical records, surgical notes, and any prior imaging or genetic test results.
2
During the Test:The test involves a simple blood draw or FTA card sample collection. No invasive procedures are involved. The sample is then transported to the DNA Labs India facility for NGS processing.
3
After the Test:After the sample is received, it undergoes DNA extraction, library preparation, NGS sequencing, and bioinformatic analysis. Clinical reporting and variant curation are completed after rigorous QC. You will receive a detailed report including the FASTQ and VCF raw data files.

About This Test

Who Should Get This Test

The primary purpose of the MID1 Gene Opitz G Syndrome NGS Genetic Test is to confirm or rule out Opitz G Syndrome in individuals presenting with suggestive clinical features. It also serves to identify carriers, guide reproductive decisions, and facilitate early intervention. The test uses NGS technology, which allows simultaneous sequencing of the entire MID1 gene coding region and intron-exon boundaries, detecting single nucleotide variants, small insertions/deletions, and splice-site mutations. This is essential for accurate diagnosis, as the clinical spectrum of Opitz G Syndrome overlaps with other midline defects. Molecular confirmation enables precise genetic counseling, risk assessment for family members, and recurrence risk estimation.

How to Prepare

  • We recommend using an EDTA vacutainer for blood collection
  • For FTA card: apply a single drop of blood onto each card circle and let it air dry for at least 1 hour before sealing in the provided pouch
  • For extracted DNA: submit at least 1-2 micrograms of high-quality DNA in a DNA-free tube
  • Label the sample with patient name, date of birth, and collection date
  • Avoid contamination by wearing gloves during collection

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"The MID1 gene plays a critical role in midline development. NGS-based testing is essential to identify pathogenic mutations in Opitz G Syndrome. Early diagnosis helps guide multidisciplinary care for affected individuals, including surgical, cardiac, and neurological intervention."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood (or as per sample type)
ContainerEDTA vacutainer / FTA card / DNA vial
Collection MethodPeripheral venipuncture / FTA spot / DNA submission

Sample Stability

Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Incorrectly labelled sample
  • Sample in non-sterile or leaking container
  • Insufficient quantity of extracted DNA
  • Sample collection tube containing anticoagulant other than EDTA

Understanding Your Results

The interpretation of the MID1 Gene Opitz G Syndrome NGS Genetic Test is performed by clinical geneticists. The report explains the presence or absence of pathogenic variants in the MID1 gene and the clinical relevance of the findings.
📊

Pathogenic or likely pathogenic variant detected

Confirms the molecular diagnosis of Opitz G Syndrome. Enables targeted surveillance and management.

📊

Variant of uncertain significance (VUS) detected

Further segregation analysis or functional studies may be required. Consultation with a geneticist is advised.

📊

No pathogenic variant detected

The absence of a MID1 mutation does not exclude Opitz G Syndrome. Consider other genes or alternative diagnoses.

⚠️ When to Consult a Doctor:

Consult a clinical geneticist or pediatric neurologist if your child shows symptoms such as hypertelorism, cleft palate, feeding difficulties, heart murmur, or urogenital anomalies. Early diagnostic testing can significantly improve outcomes through timely surgical and medical intervention.

Limitations

  • This test does not detect large gene deletions, duplications, or chromosomal rearrangements unless copy number variant (CNV) analysis is included
  • Regulatory region variants may not be identified by standard NGS
  • Results should be interpreted by a clinical geneticist in conjunction with clinical evaluation
  • Negative result does not completely exclude Opitz G Syndrome if clinical suspicion is high
  • Variant classification may require additional family co-segregation data

Risks & Considerations

  • No significant health risks are associated with blood sample collection
  • Minimal risk of hematoma or bruising at the puncture site
  • No anesthesia is required and the procedure is safe for newborns and children

Interfering Factors

  • Poor quality or degraded DNA sample
  • Incomplete clinical information provided with the test
  • Presence of a variant of uncertain significance (VUS) requiring family studies
  • Mosaic mutations may escape detection
  • Intronic variants outside the analyzed regions may not be detected

Compare With Similar Tests

TestMID1 Gene Opitz G syndrome NGS Genetic Test
ComparisonMID1 Gene Opitz G syndrome NGS Genetic Test

Frequently Asked Questions

What is Opitz G Syndrome?
Opitz G Syndrome is a rare genetic disorder caused by mutations in the MID1 gene. It affects midline structures and can lead to hypertelorism, clefts, laryngeal and tracheal abnormalities, heart defects, and urogenital anomalies. Diagnosis is confirmed by genetic testing.
How is the MID1 gene mutation detected?
The test uses Next Generation Sequencing (NGS) to analyze the entire coding region and intron-exon boundaries of the MID1 gene. This method identifies point mutations, small insertions, deletions, and splice-site variants.
What is the cost of the MID1 Gene Opitz G Syndrome NGS Genetic Test?
The cost is INR 20000 (Rs 20000.0) at DNA Labs India. This includes genetic counseling, NGS sequencing, bioinformatic analysis, clinical interpretation, and the final report.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for this test for online bookings. The service is available in over 200 cities across India.
What sample is required?
The preferred sample types are blood in an EDTA vacutainer, extracted DNA, or one drop of blood on an FTA card. All sample types are accepted and stable under proper conditions.
How long does it take to get results?
The turnaround time is typically 3 to 4 weeks from the date the sample is received at the laboratory. Reports are delivered online, via email, and on WhatsApp.
Will the report include raw data files?
Yes, DNA Labs India is transparent and provides the FASTQ and VCF raw data files along with the conclusive clinical test report. You should always ask for these files from your testing laboratory.
Who should get this test done?
This test is recommended for individuals presenting with clinical features suggestive of Opitz G Syndrome, including midline defects, cleft lip/palate, heart anomalies, or laryngeal abnormalities. It is also suitable for family members at risk of inheriting the mutation.
Is fasting required before the test?
No, fasting is not required for this genetic test. You can eat and drink normally before sample collection.
What is the role of genetic counseling in this test?
Pre-test genetic counseling is mandatory to draw a pedigree chart of family members and assess the inheritance pattern. It helps in interpreting the test results and understanding implications for family members.
Can this test detect all types of MID1 mutations?
NGS detects single nucleotide variants, small insertions/deletions, and splice-site mutations. However, large deletions, duplications, or gross chromosomal rearrangements may not be identified. Additional testing such as MLPA may be considered.
Will insurance cover the cost of this test?
Currently this test is not covered under PMJAY, CGHS, ECHS, or ESIC. Some private insurance plans may offer partial coverage for medically indicated genetic testing. Please check with your insurer.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.